BRPI0914231A2 - composto, composição farmacêutica, método para tratar um distúrbio psiquiátrico, e, uso de um composto - Google Patents

composto, composição farmacêutica, método para tratar um distúrbio psiquiátrico, e, uso de um composto

Info

Publication number: BRPI0914231A2
Authority: BR; Brazil
Prior art keywords: compound; treating; pharmaceutical composition; psychiatric disorder; psychiatric
Prior art date: 2008-06-20

Application number

BRPI0914231A

Other languages

English (en)

Portuguese (pt)

Inventor

Ashokkumar Bhikkappa Shenvi

Dan Widzowski

Dean Brown

James Campbell Muir

James Hulsizer

James R Damewood

M Edward Pierson Jr

Michael Wood

Phil Edwards

Steven Wesolowski

Original Assignee

Atrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-20

Filing date

2009-06-18

Publication date

2015-11-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41431860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0914231(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-06-18 Application filed by Atrazeneca Ab filed Critical Atrazeneca Ab

2015-11-03 Publication of BRPI0914231A2 publication Critical patent/BRPI0914231A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0914231A 2008-06-20 2009-06-18 composto, composição farmacêutica, método para tratar um distúrbio psiquiátrico, e, uso de um composto BRPI0914231A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7441708P	2008-06-20	2008-06-20
PCT/SE2009/050763 WO2009154563A1 (en)	2008-06-20	2009-06-18	Dibenzothiazepine derivatives and use thereof

Publications (1)

Publication Number	Publication Date
BRPI0914231A2 true BRPI0914231A2 (pt)	2015-11-03

Family

ID=41431860

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0914231A BRPI0914231A2 (pt)	2008-06-20	2009-06-18	composto, composição farmacêutica, método para tratar um distúrbio psiquiátrico, e, uso de um composto

Country Status (37)

Country	Link
US (3)	US20110160184A1 (me)
EP (1)	EP2307389B1 (me)
JP (2)	JP5468068B2 (me)
KR (1)	KR20110019781A (me)
CN (1)	CN102131791B (me)
AR (1)	AR072200A1 (me)
AU (1)	AU2009260905B2 (me)
BR (1)	BRPI0914231A2 (me)
CA (1)	CA2728675A1 (me)
CL (1)	CL2010001471A1 (me)
CR (1)	CR11860A (me)
CU (1)	CU23884B1 (me)
CY (1)	CY1113845T1 (me)
DK (1)	DK2307389T3 (me)
DO (1)	DOP2010000393A (me)
EA (1)	EA201001889A1 (me)
EC (1)	ECSP10010698A (me)
ES (1)	ES2402084T3 (me)
HN (1)	HN2010002683A (me)
HR (1)	HRP20130234T1 (me)
IL (2)	IL210081A (me)
ME (1)	ME01516B (me)
MX (1)	MX2010014203A (me)
MY (1)	MY157518A (me)
NI (1)	NI201000224A (me)
NZ (1)	NZ590616A (me)
PE (1)	PE20110029A1 (me)
PL (1)	PL2307389T3 (me)
PT (1)	PT2307389E (me)
RS (1)	RS52703B (me)
SI (1)	SI2307389T1 (me)
SV (1)	SV2010003769A (me)
TW (1)	TWI488854B (me)
UA (1)	UA105903C2 (me)
UY (1)	UY31919A (me)
WO (1)	WO2009154563A1 (me)
ZA (1)	ZA201100488B (me)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY157518A (en) *	2008-06-20	2016-06-15	Astrazeneca Ab	Dibenzothiazepine derivatives and use thereof
KR20160043029A (ko) *	2013-08-12	2016-04-20	그라파이트 소프트웨어 코포레이션	보안 인증 및 암호화된 도메인들로의 스위칭
CN103524455A (zh) *	2013-10-30	2014-01-22	苏州敬业医药化工有限公司	一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
CA2931289C (en)	2013-11-21	2023-10-17	Graphite Software Corporation	Managed domains for remote content and configuration control on mobile information devices
CN104447615A (zh) *	2014-02-28	2015-03-25	广东东阳光药业有限公司	喹硫平中间体的制备方法
EP4428132A1 (en) *	2023-03-08	2024-09-11	Johann-Wolfgang-Goethe-Universität Frankfurt am Main	Slack-activating compounds and their medical use
KR20250153284A (ko) *	2023-03-08	2025-10-24	요한 볼프강 괴테 우니베르시타트, 프랑크프루트 암 마인	슬랙(Slack) 활성화 화합물 및 이의 의학적 용도

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL294355A (me)
NL293201A (me)
DE1620703B2 (de) *	1960-08-16	1976-11-25	Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern	11-basisch substituierte dibenzo eckige klammer auf b,f eckige klammer zu-eckige klammer auf 1,4 eckige klammer zu-thiazepine
CH422793A (de) *	1961-07-20	1966-10-31	Wander Ag Dr A	Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine
DE1470416A1 (de)	1962-05-25	1969-05-14	Wander Ag Dr A	Verfahren zur Herstellung ll-basisch substituierter 5 H-Dibenzo[b,e],[1,4] diazepine
CH476753A (de)	1962-06-08	1969-08-15	Wander Ag Dr A	Verfahren zur Herstellung von 11-basisch substituierter Dibenzo(b,f)(1,4)thiazepine
NL140242B (nl)	1963-03-01	1973-11-15	Wander Ag Dr A	Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
BE632120A (me)	1963-05-09
US3884920A (en)	1967-07-14	1975-05-20	Sandoz Ag	11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US3908010A (en)	1967-03-22	1975-09-23	Wander Ag Dr A	Basically substituted heterocycles as anti-emetics
US3683034A (en)	1963-09-27	1972-08-08	Upjohn Co	Process for the preparation of substituted hydroquinones
US3412193A (en)	1965-12-13	1968-11-19	American Cyanamid Co	11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
US3444169A (en)	1966-01-17	1969-05-13	American Cyanamid Co	Process for 11 - aminodibenz(b,f)(1,4)oxazepines and analogous thiazepines
NL6715650A (me)	1966-12-16	1968-06-17
US3852446A (en)	1967-03-13	1974-12-03	Sandoz Ag	Organic compounds in treatment of psychotic disturbances
US3539573A (en) *	1967-03-22	1970-11-10	Jean Schmutz	11-basic substituted dibenzodiazepines and dibenzothiazepines
US3758479A (en)	1967-03-22	1973-09-11	Sandoz Ag	Nitro and sulphamoyl substituted dibenzodiazepines
US3962248A (en) *	1972-04-04	1976-06-08	Sandoz, Inc.	Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
CH569730A5 (me) *	1972-04-04	1975-11-28	Wander Ag Dr A
GB8607684D0 (en)	1986-03-27	1986-04-30	Ici America Inc	Thiazepine compounds
GB8705574D0 (en)	1987-03-10	1987-04-15	Ici Plc	Preparation of thiazepine compound
JPH04211071A (ja) *	1990-03-05	1992-08-03	Hokuriku Seiyaku Co Ltd	多環式化合物
JPH0565257A (ja)	1991-07-05	1993-03-19	Hokuriku Seiyaku Co Ltd	多環式化合物及びその用途
US5661184A (en)	1994-08-12	1997-08-26	Eli Lilly And Company	Psychiatric agents
ES2145922T3 (es)	1994-08-24	2000-07-16	Astrazeneca Ab	Compuestos espiro-azabiciclicos utiles en terapia.
US5602121A (en) *	1994-12-12	1997-02-11	Allelix Biopharmaceuticals, Inc.	Alkyl-substituted compounds having dopamine receptor affinity
SE9504661D0 (sv)	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
SE9600683D0 (sv)	1996-02-23	1996-02-23	Astra Ab	Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es)	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9702799D0 (sv)	1997-07-25	1997-07-25	Astra Ab	New compounds
AU5489299A (en)	1998-08-18	2000-03-14	Sepracor, Inc.	Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
SE9900100D0 (sv)	1999-01-15	1999-01-15	Astra Ab	New compounds
EP1200082A1 (de)	1999-07-28	2002-05-02	Oswald Wiss	Präparate mit sauerstoffsparender wirkung bei körperlicher leistung
SE9903760D0 (sv)	1999-10-18	1999-10-18	Astra Ab	New compounds
SE0002729D0 (sv)	2000-07-20	2000-07-20	Astrazeneca Ab	Novel compound form
US6630462B2 (en)	2000-11-17	2003-10-07	Adolor Corporation	Delta agonist analgesics
IL139975A0 (en)	2000-11-29	2002-02-10	Univ Ramot	Anti proliferative drugs
IL158631A0 (en)	2001-05-18	2004-05-12	Astrazeneca Ab	4-(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
ATE353332T1 (de)	2001-06-01	2007-02-15	Astrazeneca Ab	Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren
KR20040026680A (ko)	2001-07-09	2004-03-31	콤비네이토릭스, 인코포레이티드	염증 질환 치료용 조합
EP1429844B1 (en)	2001-09-27	2012-01-18	Ramot at Tel Aviv University Ltd.	Conjugate of perphenazine and gaba and uses thereof
US7544681B2 (en)	2001-09-27	2009-06-09	Ramot At Tel Aviv University Ltd.	Conjugated psychotropic drugs and uses thereof
KR20040099446A (ko)	2002-04-18	2004-11-26	아스트라제네카 아베	헤테로시클릭 화합물
JP4511195B2 (ja)	2002-04-18	2010-07-28	アストラゼネカ・アクチエボラーグ	フリル化合物
BR0309342A (pt)	2002-04-18	2005-02-15	Astrazeneca Ab	Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
SE0202465D0 (sv)	2002-08-14	2002-08-14	Astrazeneca Ab	New compounds
SE0202430D0 (sv)	2002-08-14	2002-08-14	Astrazeneca Ab	New Compounds
SE0202598D0 (sv)	2002-09-02	2002-09-02	Astrazeneca Ab	Alpha-7 Nicotinic receptor agonists and statins in combination
CN1681388A (zh)	2002-09-18	2005-10-12	Fmc有限公司	三环衍生物杀虫剂
AU2003290079A1 (en)	2002-12-20	2004-07-14	Basf Aktiengesellschaft	Pesticidal dibenzo(hetero)azepine derivatives
KR20050092123A (ko)	2003-01-23	2005-09-20	아카디아 파마슈티칼스 인코포레이티드	Ｎ-데스메틸클로자핀의 인간의 신경정신성 질환의 치료용도
EP1495008A1 (en)	2003-02-22	2005-01-12	Teva Pharmaceutical Industries Limited	Synthesis of quetiapine and pharmaceutically acceptable salts thereof
DE10310196A1 (de)	2003-03-06	2004-09-23	Rina-Netzwerk Rna Technologien Gmbh	Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose
JP2006523707A (ja)	2003-04-15	2006-10-19	アストラゼネカアクツィエボラーグ	治療化合物
US20060217366A1 (en) *	2003-07-02	2006-09-28	Astrazeneca Ab	Method of treating schizophrenia and other disorders
PL195728B1 (pl)	2003-07-18	2007-10-31	Helm Ag	Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
RU2394030C2 (ru) *	2003-12-22	2010-07-10	Акадиа Фармасьютикалз Инк.	АМИНОЗАМЕЩЕННЫЕ АНАЛОГИ ДИАРИЛ [a,d] ЦИКЛОГЕПТЕНА В КАЧЕСТВЕ МУСКАРИНОВЫХ АГОНИСТОВ И СПОСОБЫ ЛЕЧЕНИЯ ПСИХОНЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ
ES2324713T3 (es)	2003-12-22	2009-08-13	Acadia Pharmaceuticals Inc.	Analogos de diaril(a,d)ciclohepteno amino-sustituidos como agonistas muscarinicos y metodos de tratamiento de trastornos neuropsiquiatricos.
US20060063754A1 (en) *	2004-09-21	2006-03-23	Edgar Dale M	Methods of treating a sleep disorder
CN101128435A (zh)	2004-12-27	2008-02-20	阿斯利康(瑞典)有限公司	作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物
WO2006073360A1 (en) *	2005-01-07	2006-07-13	Astrazeneca Ab	NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f] [1,4] THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS
WO2006107948A2 (en) *	2005-04-04	2006-10-12	Acadia Pharmaceuticals Inc.	Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007053618A1 (en) *	2005-10-31	2007-05-10	Acadia Pharmaceuticals Inc.	Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
JP2010514683A (ja)	2006-12-20	2010-05-06	アストラゼネカ・アクチエボラーグ	化合物及びその使用
US20110053953A1 (en)	2007-02-09	2011-03-03	Abdelmalik Slassi	AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613
US7491871B2 (en)	2007-04-25	2009-02-17	Stine Seed Farm, Inc.	Soybean cultivar S060299
TWI417100B (zh)	2007-06-07	2013-12-01	Astrazeneca Ab	二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
TW200911255A (en)	2007-06-07	2009-03-16	Astrazeneca Ab	Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
MY157518A (en) *	2008-06-20	2016-06-15	Astrazeneca Ab	Dibenzothiazepine derivatives and use thereof

2009
- 2009-06-18 MY MYPI2010006035A patent/MY157518A/en unknown
- 2009-06-18 SI SI200930544T patent/SI2307389T1/sl unknown
- 2009-06-18 UY UY0001031919A patent/UY31919A/es not_active Application Discontinuation
- 2009-06-18 TW TW098120494A patent/TWI488854B/zh not_active IP Right Cessation
- 2009-06-18 NZ NZ590616A patent/NZ590616A/xx not_active IP Right Cessation
- 2009-06-18 PT PT97669535T patent/PT2307389E/pt unknown
- 2009-06-18 AU AU2009260905A patent/AU2009260905B2/en not_active Ceased
- 2009-06-18 BR BRPI0914231A patent/BRPI0914231A2/pt not_active IP Right Cessation
- 2009-06-18 DK DK09766953.5T patent/DK2307389T3/da active
- 2009-06-18 WO PCT/SE2009/050763 patent/WO2009154563A1/en not_active Ceased
- 2009-06-18 JP JP2011514540A patent/JP5468068B2/ja not_active Expired - Fee Related
- 2009-06-18 HR HRP20130234AT patent/HRP20130234T1/hr unknown
- 2009-06-18 MX MX2010014203A patent/MX2010014203A/es active IP Right Grant
- 2009-06-18 RS RS20130109A patent/RS52703B/sr unknown
- 2009-06-18 EP EP09766953A patent/EP2307389B1/en active Active
- 2009-06-18 UA UAA201015001A patent/UA105903C2/uk unknown
- 2009-06-18 CN CN200980132601.5A patent/CN102131791B/zh not_active Expired - Fee Related
- 2009-06-18 EA EA201001889A patent/EA201001889A1/ru unknown
- 2009-06-18 US US12/999,808 patent/US20110160184A1/en not_active Abandoned
- 2009-06-18 KR KR1020117001427A patent/KR20110019781A/ko not_active Ceased
- 2009-06-18 PE PE2010001170A patent/PE20110029A1/es not_active Application Discontinuation
- 2009-06-18 ME MEP-2013-27A patent/ME01516B/me unknown
- 2009-06-18 ES ES09766953T patent/ES2402084T3/es active Active
- 2009-06-18 CA CA2728675A patent/CA2728675A1/en not_active Abandoned
- 2009-06-18 PL PL09766953T patent/PL2307389T3/pl unknown
- 2009-06-19 US US12/487,725 patent/US8158618B2/en not_active Expired - Fee Related
- 2009-06-19 AR ARP090102240A patent/AR072200A1/es unknown
2010
- 2010-12-16 IL IL210081A patent/IL210081A/en not_active IP Right Cessation
- 2010-12-17 CL CL2010001471A patent/CL2010001471A1/es unknown
- 2010-12-20 NI NI201000224A patent/NI201000224A/es unknown
- 2010-12-20 SV SV2010003769A patent/SV2010003769A/es not_active Application Discontinuation
- 2010-12-20 CU CU20100252A patent/CU23884B1/es not_active IP Right Cessation
- 2010-12-20 EC EC2010010698A patent/ECSP10010698A/es unknown
- 2010-12-20 HN HN2010002683A patent/HN2010002683A/es unknown
- 2010-12-20 CR CR11860A patent/CR11860A/es unknown
- 2010-12-20 DO DO2010000393A patent/DOP2010000393A/es unknown
2011
- 2011-01-19 ZA ZA2011/00488A patent/ZA201100488B/en unknown
2012
- 2012-04-12 US US13/445,347 patent/US8653257B2/en not_active Expired - Fee Related
2013
- 2013-03-22 CY CY20131100246T patent/CY1113845T1/el unknown
- 2013-11-21 IL IL229560A patent/IL229560A/en not_active IP Right Cessation
2014
- 2014-01-27 JP JP2014011979A patent/JP2014098006A/ja active Pending

Also Published As

Publication number	Publication date
WO2009154563A1 (en)	2009-12-23
IL229560A0 (en)	2014-01-30
EP2307389B1 (en)	2013-01-23
EP2307389A4 (en)	2012-04-11
TW201002702A (en)	2010-01-16
UA105903C2 (uk)	2014-07-10
US20120202991A1 (en)	2012-08-09
PE20110029A1 (es)	2011-02-11
US20090318415A1 (en)	2009-12-24
NI201000224A (es)	2012-03-19
ES2402084T3 (es)	2013-04-26
CR11860A (es)	2011-02-25
UY31919A (es)	2010-01-29
DOP2010000393A (es)	2011-01-31
JP5468068B2 (ja)	2014-04-09
EA201001889A1 (ru)	2011-08-30
AR072200A1 (es)	2010-08-11
IL229560A (en)	2015-07-30
PL2307389T3 (pl)	2013-05-31
MY157518A (en)	2016-06-15
EP2307389A1 (en)	2011-04-13
CL2010001471A1 (es)	2011-05-06
CU20100252A7 (es)	2011-11-15
KR20110019781A (ko)	2011-02-28
US8158618B2 (en)	2012-04-17
DK2307389T3 (da)	2013-04-02
SV2010003769A (es)	2011-05-20
HRP20130234T1 (hr)	2013-04-30
HN2010002683A (es)	2013-01-15
CN102131791A (zh)	2011-07-20
ECSP10010698A (es)	2011-01-31
JP2014098006A (ja)	2014-05-29
IL210081A0 (en)	2011-02-28
US20110160184A1 (en)	2011-06-30
CU23884B1 (es)	2013-04-19
TWI488854B (zh)	2015-06-21
AU2009260905B2 (en)	2012-08-23
CY1113845T1 (el)	2016-07-27
AU2009260905A1 (en)	2009-12-23
NZ590616A (en)	2012-09-28
ZA201100488B (en)	2011-10-26
MX2010014203A (es)	2011-02-22
JP2011524898A (ja)	2011-09-08
PT2307389E (pt)	2013-03-28
US8653257B2 (en)	2014-02-18
SI2307389T1 (sl)	2013-04-30
RS52703B (sr)	2013-08-30
IL210081A (en)	2013-12-31
HK1156308A1 (en)	2012-06-08
CN102131791B (zh)	2014-12-24
CA2728675A1 (en)	2009-12-23
ME01516B (me)	2014-04-20

Publication	Publication Date	Title
BRPI0922475A2 (pt)	2017-06-06	composto, composição farmacêutica , método para tratar câncer, e, uso de um composto.
BRPI0818244A2 (pt)	2015-06-16	Composto, composição farmacêutica, uso de um composto, e, método para tratamento de um distúrbio ou doença
BRPI0913585A2 (pt)	2015-10-27	composto, método para fabricar um composto, composição farmacêutica, uso de um composto, e, método para o tratamento ou prevenção de distúrbios
BRPI1010937A2 (pt)	2019-09-24	composto, uso de um composto, e, método para tratar câncer
BRPI0917458A2 (pt)	2015-12-01	composto, método de tratamento de doenças e condições, composição farmacêutica, método para tratar ou prevenir doença, e, uso de um composto
BRPI0907976A2 (pt)	2015-08-04	Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0906475A2 (pt)	2015-07-14	Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
BRPI0814777A2 (pt)	2015-03-03	Composto, composição farmacêutica, método para tratar um neoplasma, uso de um composto, e, composição farmacêutica.
BRPI0908100A2 (pt)	2015-10-06	produto combinação, uso de um composto, e, método de tratar câncer
BRPI0909691A2 (pt)	2015-08-04	Composto, método para preparar um composto, e, composição farmacêutica
BRPI0907974A2 (pt)	2015-08-04	Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0914927A2 (pt)	2017-06-20	composto, composição farmacêutica, métodos para inibir a função de fak e de tratamento de um câncer, uso de um composto, e, processo para preparar um composto
BRPI0610514A2 (pt)	2016-11-16	composto, composição farmacêutica, e, método de tratamento de um distúrbio
BRPI0911685A2 (pt)	2015-10-13	composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit
BRPI0908252A2 (pt)	2015-07-21	Processo para preparar um composto, e, uso de um composto
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0816331A2 (pt)	2015-04-14	Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto.
BRPI0909198A2 (pt)	2019-09-24	composto antifolato, composto, método para preparar um composto antifolato, composição farmacêutica, método para tratar
BRPI0912539A2 (pt)	2015-10-13	composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
BRPI0914371A2 (pt)	2019-09-24	"composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"
BRPI0822946A2 (pt)	2015-06-23	Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida
BRPI0908883A2 (pt)	2015-09-15	composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI1012978A2 (pt)	2016-03-29	composição tópica, método para preparar a mesma, e, uso de um composto
BR112012004173A2 (pt)	2017-05-30	"composto, composição, método para preparar uma composição, e, uso de um composto"
BRPI0922714A2 (pt)	2016-01-05	composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica

Legal Events

Date	Code	Title	Description
2017-04-18	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2017-08-01	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]